Albrecht K, Strangfeld A, Marschall U, Callhoff J. Interstitial lung disease in rheumatoid arthritis: incidence, prevalence and related drug prescriptions between 2007 and 2020. RMD Open 2023;9. [PMID: 36669830 DOI: 10.1136/rmdopen-2022-002777][Reference Citation Analysis]
2
Nasonov EL, Ananyeva LP, Avdeev SN. Interstitial lung disease in rheumatoid arthritis: A multidisciplinary problem in rheumatology and pulmonology. Naučno-praktičeskaâ revmatologiâ 2022;60:517-534. [DOI: 10.47360/1995-4484-2022-1][Reference Citation Analysis]
3
Klemm P, Henes J, Xanthouli P. Interstitielle Lungenbeteiligung bei der rheumatoiden Arthritis. Arthritis und Rheuma 2022;42:324-329. [DOI: 10.1055/a-1893-4857][Reference Citation Analysis]
4
Tsujii A, Isoda K, Yoshimura M, Nakabayashi A, Kim D, Tamada T, Yamamoto K, Ohshima S. Comparison of safety and efficacy between Janus kinase inhibitors and abatacept for rheumatoid arthritis-associated interstitial lung disease.. [DOI: 10.21203/rs.3.rs-2110699/v1][Reference Citation Analysis]